The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. X4 Pharmaceuticals Inc shares valued at $46,347 were sold by Mostafa Adam S. on Mar 11 ’24. At $0.88 per share, Mostafa Adam S. sold 52,500 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Ragan Paula sold 49,678 shares, netting a total of over 43,856 in proceeds. Following the sale of shares at $0.88 each, the insider now holds 765,068 shares.
Before that, DiBiase Mary had sold 15,409 shares from its account. In a trade valued at $13,591, the Chief Operating Officer traded X4 Pharmaceuticals Inc shares for $0.88 each. Upon closing the transaction, the insider’s holdings decreased to 15,409 shares, worth approximately $0.36 million.
As published in a research note from B. Riley Securities on December 12, 2023, X4 Pharmaceuticals Inc [XFOR] has been rated down from a Buy to a Neutral and the price target has been revised to $1 from $3. As of December 22, 2022, Cantor Fitzgerald has initiated its “an Overweight” rating for XFOR. Earlier on December 12, 2022, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for XFOR stock.
Analyzing XFOR Stock Performance
During the last five days, there has been a drop of approximately -15.99%. Over the course of the year, X4 Pharmaceuticals Inc shares have jumped approximately 47.29%. Shares of the company reached a 52-week high of $1.6000 on 04/03/24 and a 52-week low of $0.7004 on 01/25/24. A 50-day SMA is recorded $1.0535, while a 200-day SMA reached $1.0941. Nevertheless, trading volume fell to 1.55 million shares from 1.85 million shares the previous day.
Support And Resistance Levels for X4 Pharmaceuticals Inc (XFOR)
According to the 24-hour chart, there is a support level at 1.1833, which, if violated, would cause prices to drop to 1.1317. In the upper region, resistance lies at 1.2783. The next price resistance is at 1.3217. RSI (Relative Strength Index) is 52.01 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.1358, which suggests the price will decrease in the coming days. Percent R is at 68.87%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is X4 Pharmaceuticals Inc subject to short interest?
Stocks of X4 Pharmaceuticals Inc saw a sharp rise in short interest on Mar 15, 2024 jumping by 0.99 million shares to 14.22 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 13.23 million shares. A jump of 6.96% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.06 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.06.
